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Pseudomonas aeruginosa can notably cause both acute and chronic infection. While several virulence factors
are implicated in the acute phase of infection, advances in understanding bacterial pathogenesis suggest that
chronic P. aeruginosa infection is related to biofilm formation. However, the relationship between these two
forms of disease is not well understood. Accumulating evidence indicates that, during acute infection, P.
aeruginosa enters epithelial cells, a process viewed as either a host-mediated defense response or a pathogenic
mechanism to avoid host-mediated killing. We investigated the possibility that epithelial cell entry during early
P. aeruginosa-epithelial cell contact favors bacterial survival and is linked to chronic infection. Using electron
microscopy and confocal microscopy to analyze primary culture airway epithelial cells infected with P.
aeruginosa, we found that epithelial cells developed pod-like clusters of intracellular bacteria with regional
variation in protein expression. Extracellular gentamicin added to the medium after acute infection led to the
persistence of intracellular P. aeruginosa for at least 3 days. Importantly, compared to bacterial culture under
planktonic conditions, the intracellular bacteria were insensitive to growth inhibition or killing by antibiotics
that were capable of intraepithelial cell penetration. These findings suggest that P. aeruginosa can use airway
epithelial cells as a sanctuary for persistence and develop a reversible antibiotic resistance phenotype char-
acteristic of biofilm physiology that can contribute to development of chronic infection.
Pseudomonas aeruginosa is remarkable in that it can cause
both very acute and very chronic infections (34). Progress in
understanding the pathogenesis of acute P. aeruginosa infec-
tions has implicated virulence factors including exotoxin A and
type III secreted exotoxins (33, 39, 44). Understanding the
pathogenesis of the chronic infections caused by P. aeruginosa
is also progressing. Current concepts propose that biofilm for-
mation is a key factor in chronic Pseudomonas airway infection
in cystic fibrosis and bronchiectasis and chronic urinary tract
and device-related infections (17, 29, 32, 40). However, much
remains to be learned about how acute infections progress to a
chronic phase.
Recent work suggests that many bacteria that are usually
considered to have a primary pathogenic effect while extracel-
lular also have the capacity to invade and perhaps reside in
host cells during the early phase of infection. In the bladder,
Escherichia coli has been found to persist within epithelia as
“pods” in a mouse model of urinary tract infection (2). In this
model, bacteria within the pods assumed a biofilm structure to
resist host killing and to function as an intracellular “factory”
for subsequent bacterial efflux into the bladder lumen, contrib-
uting to persistent infection. In the lung, discovery of intraepi-
thelial Haemophilus influenzae in biopsy samples of airway
epithelial cells from individuals with chronic obstructive lung
disease harboring persistent antibiotic-resistant organisms im-
plicates intracellular bacteria as an additional reservoir for
infection (3, 26). Experimental studies using cell lines and
animal models of acute lung infection showed that P. aerugi-
nosa can move intracellularly soon after infection (16, 24, 31,
38, 47). Most recently, in vitro studies using airway epithelial
cell lines demonstrated that these bacteria are capable of in-
traepithelial survival for up to 24 h without cytotoxicity (10).
The observation that traditional extracellular organisms can be
found intracellularly and the finding that E. coli within bladder
cells forms biofilms raise the intriguing possibility that the
intracellular bacteria may also play a role in persistent P.
aeruginosa infections.
Here, we examined the events occurring after initial epithe-
lial cell entry. Our data reveal that internalized bacteria have
biofilm-like characteristics. Namely, following acute exposure,
P. aeruginosa formed as clusters within airway cells and these
epithelia tolerated the internalized bacteria for long periods.
Importantly, the intracellular bacteria also developed a revers-
ible antibiotic resistance phenotype. The findings indicate that
epithelial entry of P. aeruginosa can favor persistence and may
contribute to difficulties in the treatment of airway infection.
MATERIALS AND METHODS
Bacteria and culture. P. aeruginosa strains used were PAO1 and PAO1-GFP
(green fluorescent protein) (11) (both resistant to chloramphenicol, 50 g/ml;
kindly provided by M. Parsek, University of Iowa), PAK (kindly provided by S.
Lory, Harvard University), and a mucoid clinical strain (clinical strain 1 [CS1])
isolated from an individual with cystic fibrosis by the Laboratory of Clinical
Microbiology at Barnes-Jewish Hospital (St. Louis, MO). Strains were stored as
a stock at 80°C. For each set of experiments, bacteria were streaked onto a
Luria-Bertani (LB) agar medium plate and cultured for 18 to 22 h at 37°C. An
individual colony was cultured in LB medium and then amplified in a larger
volume to prepare aerated, log-phase bacteria by rotary shaking at 37°C until 1
 109 to 2  109 CFU/ml was achieved as determined by spectrophotometry
(optical density at 600 nm  0.6). CFU of bacteria were quantified by plating
serial dilutions on LB agar medium.
* Corresponding author. Mailing address: Washington University
School of Medicine, Box 8052, 660 South Euclid Avenue, St. Louis,






arch 3, 2014 by W







MTEC. Primary culture mouse tracheal epithelial cells (MTEC) were estab-
lished on membranes using air-liquid interface conditions as described previously
(46). Cells were harvested from tracheas by pronase digestion, and epithelial cells
were selected by differential adherence. To initiate cultures, 8  104 cells/cm2
were seeded on supported polyester semipermeable (0.4-m pore) membranes
(0.33 cm2; Transwell; Costar-Corning, Corning, NY) coated with type I rat tail
collagen (Becton Dickinson) in 0.02 M acetic acid. Cells were grown in “basic
medium” composed of Dulbecco modified Eagle medium–Ham’s F-12 with 30
mM HEPES, 4 mM L-glutamine, 3.5 mM NaHCO3, amphotericin, and penicillin-
streptomycin, supplemented with 10 g/ml insulin, 10 g/ml transferrin, 0.1
g/ml cholera toxin, 25 ng/ml epithelial growth factor (Becton Dickinson, Bed-
ford, MA), 30 g/ml bovine pituitary extract, 0.01 mM retinoic acid, and 5% fetal
bovine serum. Medium was maintained in upper and lower chambers until the
transmembrane resistance was 1,000  · cm2 corresponding to tight junction
formation and sufficient to prevent medium from leaking into the apical com-
partment (46). Then the air-liquid interface condition was established for induc-
tion of differentiation by aspirating apical chamber medium and changing the
medium in the lower compartment to serum-free basic medium supplemented
with 5 g/ml insulin, 5 g/ml transferrin, 5 ng/ml epidermal growth factor, 30
g/ml bovine pituitary extract, 1 mg/ml bovine serum albumin, and 0.01 M
retinoic acid. Cells used in studies were cultured in air-liquid interface conditions
for at least 7 days, at which time ciliated and secretory cells were present.
Inoculation of MTEC with P. aeruginosa. One day prior to bacterial inocula-
tion, the medium of MTEC was replaced with infection medium composed of
serum-free basic medium without antibiotics. Cholera toxin was removed from
the medium to allow normal ceramide trafficking in P. aeruginosa-infected cells
(19). Bacteria were resuspended in the infection medium as 106 to 107 CFU/150
l that was applied to the apical compartment of an 0.33-cm2 Transwell mem-
brane insert.
EM. Cells on membranes were prepared for scanning electron microscopy
(EM) as previously described (25). Briefly, samples were fixed with 2.5% glutar-
aldehyde, stained with 1.25% osmium tetroxide, sputter coated with gold, and
then visualized on a Hitachi S-450 microscope (Tokyo, Japan).
Immunohistochemistry and confocal microscopy. Cells on supported mem-
branes were fixed with 4% paraformaldehyde in phosphate-buffered saline
(PBS), pH 7.4, for 10 min at 25°C and immunostained as described previously
(46). Rabbit anti-P. aeruginosa flagellin (FlgA; kindly provided by A. Prince,
Columbia University) and mouse anti-P. aeruginosa outer coat protein F
(OprFMA4; kindly provided by R. E. W. Hancock, University of British Colum-
bia) were detected by fluorescent dye-labeled secondary antibodies (Jackson
ImmunoResearch Laboratories, West Grove, PA). Filamentous actin was de-
tected using rhodamine-labeled phalloidin (Molecular Probes, Eugene, OR)
incubated with fixed samples for 30 min at 25°C. Membranes containing cells
were mounted on glass slides using medium (Vectashield; Vector Laboratories,
Burlingame, CA). Microscopy was performed using a Zeiss laser scanning con-
focal system with LSM-510 software (Zeiss, Thornwood, NY). Images were
composed using Photoshop and Illustrator software (Adobe Systems, San Jose,
CA).
Recovery of intracellular bacteria. The gentamicin survival assay was used to
detect intracellular bacteria based on the inability of this agent to penetrate
epithelial cells to achieve sufficient concentrations to kill intracellular bacteria
(13, 24, 31). Following incubation with bacteria, MTEC on supported mem-
branes were washed twice for 5 min with sterile PBS, incubated with 50 g/ml
gentamicin for 30 min, and washed twice again. The membranes were then cut
out of the plastic support and transferred to a 1.5-ml plastic tube. There the
epithelial cells were lysed by incubation with lysis buffer (0.25% Triton X-100 in
PBS) for 3 min and then diluted and plated onto antibiotic-free agar medium and
incubated (18 h, 37°C) for subsequent determination of intracellular CFU. No
bacteria were recovered from apical surface washes of epithelia following treat-
ment with gentamicin for 30 min and up to 4 h. Thus, to minimize time for
possible intracellular proliferation, gentamicin treatment for 30 min was used for
studies.
Bacterial killing assays. The antibiotics ceftazidime (Eli Lilly, Indianapolis,
IN) and ciprofloxacin (Bayer Corp., Pittsburgh, PA), which are known to accu-
mulate intracellularly and are employed for the treatment of clinical P. aerugi-
nosa infections, were used for in vitro bacterial killing assays (4, 9). The MICs of
these antibiotics were determined using Etest assays (AB Biodisk, Solna, Swe-
den). Planktonic-phase bacterial killing was assayed following rotary shaking of
bacteria at 37°C in the presence of antibiotics by quantification of CFU on agar
medium. Intracellular bacterial killing assays were performed in MTEC incu-
bated with P. aeruginosa, treated with 50 g/ml gentamicin for 30 min to kill
extracellular bacteria, washed, and incubated with ceftazidime or ciprofloxacin in
the upper and lower chambers of the membrane support for the indicated time.
Cells on the membranes were then lysed, and CFU of surviving intracellular
bacteria were determined as described above.
Intracellular fluoroquinolone assay. Accumulation of intracellular ciprofloxa-
cin in MTEC was measured based on the methods of Mortimer and Piddock
(27). Ciprofloxacin fluorescence was measured over a range of concentrations
using excitation at 279 nm and emission at 447 nm detected by fluorometric
spectrophotometry (Spectra Max Gemini; Molecular Devices, Sunnyvale, CA).
Cell volume per insert was determined based on cell number, height, and radius
obtained from scanning and transmission EM and an assumed 50% intracellular
water-soluble compartment in each cell (V  r2h · 0.50  0.82 l/insert), a
method used by others (8). Ciprofloxacin in serum free-medium was applied to
the apical surface of MTEC, and they were incubated at 37°C for 4 h. Cell-
associated fluoroquinolone fluorescence was measured in triplicate samples after
MTEC were washed four times and collected in 100 ml of lysis buffer. The
concentration of ciprofloxacin was calculated at 4 h for MTEC samples com-
pared to the standards (also diluted in lysis buffer).
Statistical analysis. CFU of bacteria were analyzed using a one-way analysis of
variance (ANOVA). If significance was achieved by one-way analysis, post-
ANOVA comparison of means was performed using Scheffe’s F test. Data from
samples evaluated by a single measure of transepithelial cell resistance were
analyzed using the Kruskal-Wallis test and subjected to the Wilcoxon rank sum
test. Studies using repeat measure of transepithelial cell resistance were analyzed
using the Friedman two-way ANOVA. The level of significance for all analyses
was 	0.05.
RESULTS
The effect of P. aeruginosa on integrity of primary cultured
mouse tracheal epithelial cell layers. To determine responses
of differentiated airway epithelial cells to P. aeruginosa, mouse
tracheal epithelial cells (2  105/well) cultured using air-liquid
interface conditions were exposed to 106 to 107 CFU of strain
PAO1 for 0 to 10 h, similar to conditions used for prior studies
of P. aeruginosa pathogenesis in other cell types (7, 24, 31). As
a measure of cell viability, we monitored the transepithelial cell
resistance during infection. Although this level of transmem-
brane resistance is higher than in vivo (20), the maintenance of
high resistance observed during the initial 8 h of infection
indicated intactness of the cell layer (Fig. 1A). After 10 h, some
cells lifted off the membrane as described previously (24, 31),
and a fall in transmembrane resistance was observed. When
imaged by scanning EM at 10 h, bacteria were observed that
appeared to be associated with a defect in the apical mem-
brane of epithelial cells (Fig. 1B, detail in right panel). These
cells containing bacteria were part of the intact layer of epi-
thelia rather than sloughed cells. These findings suggested that
bacteria may enter, persist within, and/or exit the epithelial cell
during acute infection, and therefore we designed a series of
studies to investigate this pathway.
Time-dependent changes in intracellular abundance of P.
aeruginosa. Most studies of P. aeruginosa internalization have
been performed in cell lines, so as an initial characterization of
the MTEC model we used GFP-labeled bacteria detected by
laser scanning confocal microscopy. Intracellular PAO1 la-
beled with GFP (PAO1-GFP) was incubated with MTEC
which were washed and then treated with gentamicin to kill
extracellular bacteria. Confocal micrographs showed that the
GFP signal occurred as clusters within cells (Fig. 2A). To
further characterize intracellular survival of P. aeruginosa, we
used the gentamicin survival assay to kill only extracellular
bacteria and recovered bacteria after epithelial cell lysis (13,
24, 31). Intracellular P. aeruginosa abundance, evaluated after
incubation with bacteria for 4 h followed by gentamicin treat-
ment, was observed to occur at similar amounts for PAO1,
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PAO1-GFP, PAK (another laboratory strain), and a mucoid
clinical isolate called CS1 (from Barnes-Jewish Hospital, St.
Louis, MO), indicating that the phenomenon was not uniquely
strain specific (Fig. 2B). We next sought to characterize the
temporal nature of internalization of bacteria during the acute
incubation. The abundance of intracellular bacteria recovered
after 30-min to 8-h periods of incubation with P. aeruginosa
increased over time (Fig. 2C). We could not accurately mea-
sure intracellular bacteria at 10 h because some epithelial cells
lifted off the membrane at this time due to a cytotoxic effect of
intra- and/or extracellular bacteria.
P. aeruginosa forms intracellular pods. To begin to assess
bacterium-epithelial cell interactions during loss of cell layer
integrity, we used EM to compare differences in cell morphol-
ogy between 8 and 10 h. Scanning electron photomicrographs
obtained following incubation of MTEC with PAO1 for 8 h
revealed multiple pod-like cells and few extracellular bacteria.
However, after 10 h, open epithelial cells filled with bacteria
were present (Fig. 3). This pod-like appearance was similar to
that first described in airway epithelial cells following ex vivo
infection of monkey trachea and in vivo infection of mouse
lung (38). It was also reminiscent of the pods of E. coli that
formed biofilms within the large epithelial cells lining the blad-
der (2), leading us to consider that the intracellular P. aerugi-
nosa may similarly have biofilm-like characteristics.
Persistence of intracellular P. aeruginosa. An important
characteristic of bacteria that assume biofilm physiology is the
ability to survive in a confined location (29). To determine if P.
aeruginosa could persist within epithelial cells in an intact ep-
ithelial layer (for more than 8 h), we incubated MTEC with
PAO1-GFP for 4 h and then added fresh gentamicin-contain-
ing medium daily (in upper and lower chambers) for up to 72 h.
FIG. 1. Effect of P. aeruginosa on integrity of primary cultured mouse tracheal epithelial cell layers. A. Transepithelial resistance (Rt) of MTEC
incubated with P. aeruginosa. PAO1 (106 to 107 CFU) was applied to the apical surface of MTEC (2  105 cells) for up to 10 h. Values are the
means 
 standard deviations (n  3 to 9 samples/time). The dashed line represents the lower limit of Rt corresponding to maintenance of tight
junctions (46). Mechanical injury (mech inj) induced by scraping an uninfected cell layer is shown as a reference. A significant difference at 10 h
(P 	 0.05) compared to other times is indicated (*). B. Scanning EM of cells obtained 10 h after inoculation with control medium or P. aeruginosa
(Pa) as in panel A. The boxed region (center panel) showing bacteria either entering or emerging from the apical membrane of cells is enlarged
in the right panel. Bars  5 m (left and center panels); 1 m (right panel).
FIG. 2. Time-dependent changes in intracellular abundance of P. aeruginosa. A. Representative laser scanning confocal photomicrograph (xy)
and z-axis reconstruction of MTEC stained with rhodamine-labeled phalloidin (red) to identify filamentous actin, obtained 4 h after incubation with
PAO1-GFP and then gentamicin to kill extracellular bacteria. Bar 10 m. B. Gentamicin survival assay of MTEC incubated for 4 h with indicated
strains of P. aeruginosa (CS1, clinical strain). PAO1-GFP treated with paraformaldehyde prior to assay is indicated (“fixed”). MTEC were
incubated with bacteria and then treated with gentamicin, lysed, and cultured on solid medium to determine surviving intracellular bacteria
(CFU/well). Shown is the mean 
 standard deviation of triplicate samples from a representative experiment. C. Gentamicin survival assay of P.
aeruginosa PAO1-GFP strain following 0.5 to 8 h of incubation with MTEC performed as for panel B. Shown are means 
 standard deviations
of replicate samples from at least three experiments. A significant difference (P 	 0.05) from 0.5 h and 2 h is at 4 h (*) and from 0.5 and 4 h is
at 8 h (**).
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This treatment achieved killing of extracellular bacteria as
demonstrated by a failure to recover bacteria from the apical
or basolateral medium over the 72-h period. Assessment by
light microscopy and scanning EM showed that cell layers
remained intact during constant gentamicin treatment. To con-
firm the microscopic inspection, we again monitored cell layer
integrity by measurement of transepithelial resistance. The
maintenance of high resistance over the 72-h period also dem-
onstrated the viability of the epithelial cell layer (Fig. 4A).
Evaluation by confocal microscopy showed that, after 24-h
treatment with gentamicin, dense intracellular clusters of
PAO1-GFP could be found in complexes of epithelia and were
encased by septa of remodeled actin (Fig. 4B). The abundance
of recovered intracellular bacteria was similar when gentami-
cin incubation was extended from 24 to 72 h (Fig. 4C). The
prolonged persistence of intracellular P. aeruginosa suggested
that bacteria could be organizing into communities that fa-
vored intracellular survival and are tolerated by an intact epi-
thelium.
Heterogeneity of P. aeruginosa gene expression in intracel-
lular bacteria within pods. Biofilms generated using in vitro
systems display regional variation in gene expression within the
bacterial communities (35). Heterogeneous bacterial gene ex-
pression was also noted in bladder epithelial cells of mice
infected with E. coli (2). To test for this possibility in our
model, the mucoid clinical strain CS1 was incubated with
MTEC for 4 h and then maintained for 24 h in gentamicin
prior to assay for expression of FlgA, a protein that is de-
creased in biofilm communities under some conditions (43), or
outer membrane protein OprF, reported to be upregulated in
biofilms (45). As a control, gene expression was compared to
CS1 cultured using planktonic conditions. Under planktonic
conditions bacilli expressed FlgA but not OprF (Fig. 4D).
However, when intracellular, there was heterogeneity of FlgA
and OprF expression within the bacterial communities of the
pods (Fig. 4E). Thus, these intracellular bacterial pods had
acquired a shift in gene expression as seen in the E. coli-
infected bladder cells and shared some features of P. aerugi-
nosa biofilms generated in vitro.
Intracellular bacterial clusters exhibit impaired antibiotic
killing characteristic of biofilms. Biofilm bacteria notably have
antibiotic resistance that reverses when the biofilms are dis-
rupted and the cells are cultured in planktonic conditions (1,
42). To determine if intraepithelial bacterial clusters exhibited
FIG. 3. P. aeruginosa forms intracellular pods. Scanning electron
photomicrographs of MTEC obtained 8 and 10 h after incubation with
strain PAO1. Cells were incubated as in Fig. 1. Images are from two
independent preparations (top and bottom). Bars  5 m.
FIG. 4. Persistence and heterogeneity of gene expression of intracellular P. aeruginosa. A. Transepithelial cell resistance (Rt) of MTEC
incubated with PAO1-GFP for 4 h, treated with fresh medium containing gentamicin daily for up to 72 h. The dashed line represents the level of
Rt associated with maintenance of epithelial cell tight junctions (46). Values are the means 
 standard deviations of replicate samples from three
independent preparations. B. Gentamicin survival assay of recovered intracellular bacteria (CFU/well) from MTEC incubated with PAO1-GFP as
in panel A. Values are the means 
 standard deviations of triplicate samples from three independent experiments. C. Laser scanning confocal
photomicrograph (x, y) and z-axis reconstruction of MTEC stained with rhodamine-labeled phalloidin (red), obtained after incubation with
PAO1-GFP for 4 h followed by gentamicin for 24 h. Bar  10 m. D. Immunofluorescence photomicrograph of P. aeruginosa strain CS1 cultured
using planktonic conditions, applied to a glass slide, and then immunostained for FlgA (red) and/or OprF (green). Accompanying DAPI
(4,6-diamidino-2-phenylindole)-stained images are below (background was inverted to white for contrast). Bar  1 m. E. Confocal photomi-
crograph (x, y) and z-axis reconstruction of MTEC obtained after incubation with CS1 immunostained for FlgA (red) and OprF (green). White
lines indicate Transwell membrane and apical cell border. Bar  10 m.
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this biofilm characteristic, we treated epithelial layers infected
with PAO1-GFP or CS1 with antibiotics that are capable of
intracellular penetration. Ceftazidime and ciprofloxacin were
assayed for killing because these antibiotics are used to treat
clinical Pseudomonas infections and achieve high levels in tis-
sue and ciprofloxacin in particular can be concentrated in air-
way cells above delivered concentrations within 1 h (4, 8, 9). In
the planktonic state, 104 CFU of PAO1-GFP (the approximate
number of bacteria found inside cells at 4 h) was completely
killed by 0.02 g/ml of ceftazidime and 0.2 g/ml of ciprofloxa-
cin after a 2-h treatment. However, these antibiotic concentra-
tions were much less effective against epithelial layers that had
been infected with PAO1-GFP for 4 h (to allow intracellular
entry). Even a 100-fold concentration above that required for
complete killing of bacteria cultured planktonically did not
eradicate the intracellular bacteria (Fig. 5B). Similar studies
performed using the clinical isolate CS1 also revealed incom-
plete antibiotic killing of intracellular bacteria compared to
planktonic bacteria (Fig. 5E and F). Ciprofloxacin measured by
fluorescent spectroscopy in MTEC after 4 h of incubation
showed that 100 mg/ml and 20 mg/ml achieved intracellular
concentrations of 87.1 
 1.78 (standard deviation) mg/ml and
17.3 
 0.62 (standard deviation) mg/ml, respectively, consis-
tent with the rapid uptake and intracellular concentration of
this drug previously described (8). However, even after incu-
bation of infected MTEC with antibiotics for 24 h, intracellular
killing of either strain was not enhanced (Fig. 5B, D, and F).
Reversibility of the intracellular bacterial antibiotic resis-
tance phenotype. To determine if internalized bacteria had
acquired antibiotic insensitivity due to mutation or due to their
mode of growth inside epithelia, the intracellular bacterial
structures were disrupted in lysis buffer and the bacteria were
grown planktonically. Planktonic growth restored antibiotic
sensitivity to both PAO1-GFP and CS1 strains. The antibiotic
sensitivity of the recovered bacteria was identical to that of
naı¨ve organisms (bacteria never internalized), demonstrating
100% killing. These data suggest that genetic mutations were
not responsible for changes in antibiotic sensitivity and are
consistent with the biofilm-like morphology of the intraepithe-
lial cell clusters.
Fate of bacteria in epithelial cells. Individuals with chronic
airway diseases have P. aeruginosa biofilms within a complex of
sloughed cells and mucus (32, 34). To follow the fate of bac-
teria in the in vitro model, we examined cells and debris that
were retained on the apical (luminal) side of the cell culture
preparation when not treated with antibiotics or after antibi-
otics were withdrawn following prolonged exposure to genta-
micin. As noted, P. aeruginosa exposure caused cell death at
10 h and resulted in the ejection of bacterial clusters and
epithelial cell pods of intracellular bacteria (with OprF expres-
sion) onto the cell culture layer (Fig. 6A and B). These obser-
vations are consistent with several potential bacterial fates
including clearance (in vivo), intraluminal infection, dissemi-
nation, or contribution to intraluminal biofilm communities
within the airways.
DISCUSSION
Biofilms have been implicated in several types of chronic P.
aeruginosa infections occurring in individuals with cystic fibro-
FIG. 5. Efficacy of intracellular P. aeruginosa killing by antibiotics.
A. Survival of P. aeruginosa PAO1-GFP (104 CFU) cultured using
planktonic conditions in the presence of control medium or ceftazi-
dime for an additional 2 h. B. Recovery of intracellular PAO1-GFP
from MTEC, 2 and 24 h after incubation with ceftazidime. Intracellu-
lar bacteria were established by incubation of MTEC with P. aerugi-
nosa for 4 h, washed, treated with gentamicin for 30 min as in Fig. 2,
and then incubated with control medium or ceftazidime for 2 h or 24 h,
followed by cell lysis and culture on solid medium. C. Survival of
planktonic PAO1-GFP treated with ciprofloxacin as in panel A. D.
Recovery of intracellular PAO1-GFP from MTEC infected as in panel
B, after incubation with ciprofloxacin. E. Survival of strain CS1 cul-
tured planktonically and treated with ciprofloxacin as in panel C. F.
Recovery of intracellular CS1 from MTEC infected as in panel C and
treated with ciprofloxacin. Values represent the means 
 standard
deviations of three to six samples from a representative experiment of
at least three different preparations. A significant difference (P	 0.05)
from untreated bacteria is indicated (*), as is a significant difference at
2 h compared to 24 h (**).
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sis and other forms of bronchiectasis (22, 29, 32). This is con-
sistent with the established view that P. aeruginosa is primarily
an extracellular pathogen. However, several recent studies per-
formed in various epithelial cell and animal models have dem-
onstrated that P. aeruginosa can also enter host cells early in
the bacterium-epithelial cell interaction and in vivo appear as
intracellular clusters (16, 31, 38, 47). A relationship between
intracellular P. aeruginosa and development of biofilm has not
been reported, but the recent description of the biofilm prop-
erties of intracellular E. coli raises the possibility that other
organisms use a similar pathogenic mechanism. Our studies
showed that P. aeruginosa also acquires biofilm-like features
after entering epithelial cells. The bacteria formed dense, pod-
like aggregates within epithelia similar to those seen in mouse
P. aeruginosa lung and E. coli bladder infection models (2, 38).
Importantly, we found that the in vitro intracellular bacteria
demonstrated marked resistance to antibiotic killing that was
reversed when bacteria were cultured planktonically. Further-
more, P. aeruginosa survival was tolerated within intraepithe-
lial structures for relatively prolonged periods. The findings led
us to conclude that epithelial entry of P. aeruginosa may con-
tribute to difficulties in bacterial eradication associated with
acute or chronic airway infection.
Despite the increasing implication of biofilms as a cause of
human infections, there are not firm criteria to define biofilm
growth in vivo. Biofilms are a growth mode, rather than a fixed
property of bacteria, and, as a complex community, are highly
heterogeneous in behavior (6, 35, 36, 41). Identifying biofilm
growth is complicated by the fact that, in many human infec-
tions, biofilm and planktonic bacteria may coexist and, when
organisms isolated from in vivo sites are cultured ex vivo, the
biofilm phenotype rapidly reverts. In view of these challenges,
we have applied a proposed set of criteria to define biofilm-like
properties in our model of intracellular P. aeruginosa (17, 29,
41). These include, first, finding infecting bacteria in cell clus-
ters (as we observed) or microcolonies associated with a sur-
face. Second, biofilms are normally confined to a particular
location and involve less host injury than the acute infections
caused by free-living bacteria, consistent with the survival of
epithelial cells in the presence of extracellular gentamicin that
we demonstrated. Third, biofilms show marked antibiotic re-
sistance in vivo despite susceptibility to killing in the planktonic
state. Finally, bacterial biofilms are typically encased in an
extracellular polymeric matrix. The intraepithelial P. aerugi-
nosa clusters described in our study manifested most of these
characteristics including a biofilm morphology, reversible an-
tibiotic resistance, and moderated host injury. But we did not
see definite evidence for an extracellular polymeric matrix sur-
rounding the clusters, in part due to the inability of transmis-
sion EM to identify clearly identifiable clusters of intracellular
bacteria. Reasons for this may include the relative infrequency
of the large intracellular formations, the ease with which cells
filled with bacteria (which may be undergoing apoptosis) wash
off the membrane during rigorous EM sample preparation, or
a change in bacterial size or shape making intracellular bacte-
ria difficult to identify (5). However, we were able to identify
many of the other features of biofilms in the intracellular P.
aeruginosa.
Specific changes in P. aeruginosa gene expression that could
define intracellular biofilms are also unknown, since most stud-
ies of biofilms are performed using in vitro reactors under a
variety of conditions. We cannot exclude the possibility that
the changes in intracellular gene expression that we observed
were induced by epithelial cell factors rather than a biofilm
environment per se. Related to this issue is the identification of
specific bacterial genes necessary for creation of intracellular
FIG. 6. Fate of intraepithelial P. aeruginosa and model. A. Scanning electron photomicrograph of sloughed pod of airway epithelial cell
containing bacteria on the MTEC layer obtained 10 h after incubation with PAO1. Arrows indicate other bacteria adherent to cilia. Bar  5 m.
B. Confocal scanning photomicrograph (z-axis reconstruction) of MTEC incubated with P. aeruginosa clinical sample (CS1) for 4 h and then with
gentamicin for 24 h, demonstrating sloughed cells filled with bacteria (arrows) on top of the MTEC layer. Cells were immunostained with antibody
to OprF detected with fluorescein isothiocyanate (green) to identify P. aeruginosa (Pa) and rhodamine-phalloidin (red). C. Model of bacterial
internalization and release into the airway lumen. Following entry into airway epithelial cells, P. aeruginosa bacteria proliferate to form pods.
Bacteria within cells form biofilm-like communities. Subsequent cell death results in ejection of epithelia filled with bacteria into the airway, where
bacteria may contribute to airway biofilm formation and persistent P. aeruginosa infection in the lung.
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biofilms. It is likely that bacterial functions required for biofilm
formation vary in different environmental conditions. For ex-
ample, mutations in the P. aeruginosa quorum-sensing system
have pronounced effects on biofilm development in some con-
ditions but minimal effects in others (21, 37). Testing geneti-
cally deficient bacteria for intracellular biofilm formation is
also difficult in the MTEC system since many strains deficient
in candidate “biofilm genes” also have defects in adherence,
motility, and/or epithelial cell invasion (15, 18, 28).
Prior studies of intracellular P. aeruginosa have focused on
bacterial host factors that are required for binding and entry
rather than the fate of the intracellular bacteria. Those findings
indicate a requirement for the bacterial ligand flagellin (14, 15)
and putative roles for airway epithelial cell molecules asialo-
GM1, CFTR, and CD95 as receptors for adherence and entry
(12, 19, 30). Epithelial cytoskeletal rearrangement and cer-
amide activation of sphingolipid-rich raft proteins further fa-
cilitate P. aeruginosa entry (19, 23, 47). While these epithelial
cell factors may be initially required for development of intra-
cellular biofilms, the expression of genes (epithelial and bac-
terial) that favor host cell survival may also be important.
After entry, one paradigm of P. aeruginosa pathogenesis is
that programmed cell death rapidly commences, leading to
ejection of the epithelial cell filled with bacteria into the lumen
followed by prompt removal by professional phagocytes (7, 19,
30). It is likely that, in our model, this mode of cell death was
operative but without the subsequent immune cell phagocyto-
sis in the MTEC system. While epithelial cell internalization
may favor clearance by phagocytosis in mice with normal host
defense, individuals with genetic or acquired deficiencies in
airway clearance may retain intracellular pods filled with bac-
teria and increase the lung burden of bacteria, ultimately fa-
voring biofilm formation.
The role of intracellular bacteria in the human airway is not
well defined either in healthy hosts or in those with impaired
clearance. To date, intracellular P. aeruginosa has not been
identified in clinical samples. Only recently has H. influenzae,
another respiratory pathogen typified as extracellular, been
localized within airway epithelial cells (3, 26). It is possible that
intracellular P. aeruginosa is particularly difficult to find in
human samples for several reasons. First, if epithelial cells
containing bacteria are rapidly ejected from the epithelium
and phagocytosed, then fewer intracellular bacteria will be
found. Second, diagnostic or other histopathologic studies of
infection are typically performed only in individuals with
chronic, rather than acute, infection, possibility resulting in
evaluation of populations of bacteria with behaviors different
(i.e., noninvasive) from those in the acute infection (36, 37, 43).
Animal model data suggest that internalization of bacteria
occurs rapidly following acute infection (38, 47), and to our
knowledge, clinical samples from patients acutely infected with
P. aeruginosa have not been systematically examined for intra-
cellular bacteria.
In summary, our data suggest a model (Fig. 6C) for early
pathogenesis of P. aeruginosa whereby epithelial cells provide
a sanctuary for bacterial proliferation into biofilm-like commu-
nities. These intracellular bacteria may contribute to the com-
mon clinical finding of impaired antibiotic killing. Persistence
of these intracellular bacteria and sloughing of epithelial cells
containing these bacteria may contribute to a larger burden of
luminal biofilm, making bacterial eradication by antibiotics
difficult and favoring bacterial survival in the host airway.
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